In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients. The new ...

AstraZeneca has become the first company to get approval for the combination of an immunotherapy with a PARP inhibitor for treating endometrial cancer. The European Commission has cleared AZ's PD-L1 ...

Switching to an adjustable bed can be a game-changer for your sleep, particularly if you struggle with issues like snoring, nighttime reflux and chronic pain. Based on our sleep team’s expertise, ...

I'm PCMag's managing editor for consumer electronics, overseeing an experienced team of analysts covering smart home, home entertainment, wearables, fitness and health tech, and various other product ...